^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1)

i
Other names: NFKB1, KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
3d
Modulation of inflammatory and oxidative stress pathways by ethanolic extract of Suaeda fruticosa Forssk. Ex J.F.Gmel in animal models of ulcerative colitis. (PubMed, Inflammopharmacology)
Animals were treated with 125, 250, and 500 mg/kg of SF-Et, 500 mg/kg of sulfasalazine, and 10 mg/kg of the compound combination (CC)...ADMET prediction showed good intestinal absorption (> 90%) and a relatively low toxicity profile of studied compounds. These findings confirm that S. fruticosa and its major compounds can mitigate UC development by modulating inflammatory and oxidative stress biomarkers.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • IL1B (Interleukin 1, beta)
5d
Impact of Cellular Senescence on LCN2 Expression in Salivary Gland Epithelial Cells and Oral Keratinocytes. (PubMed, Biofactors)
The source of IL-1β was not senescent fibroblasts, but M1 macrophages that accumulate with inflammaging. Collectively, these results suggest that aging up-regulates LCN2 expression in oral-related epithelial cells mainly via IL-1β secreted from M1 macrophages, rather than through the induction of their senescence.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • LCN2 (Lipocalin-2) • CGAS (Cyclic GMP-AMP Synthase) • IL1B (Interleukin 1, beta)
7d
Effects of Polygonum cognatum Meissn. through modulation of hyperglycaemia, oxidative stress via Nrf-2/HO-1, apoptosis, NF-κB/TLR-4 pathways. (PubMed, J Mol Histol)
PCE downregulated the expression of caspase-3 and nuclear factor kappa B (NF-κB) and B-cell lymphoma 2 (Bcl-2) associated X-protein (Bax) and toll like receptor 4 (TLR-4) but it increased the expression of Bcl-2 and nuclear factor erythroid 2-related factor 2 (Nrf-2) and heme oxygenase-1 (HO-1). The research showed that PCE treatment resulted in decreased blood sugar levels and better liver enzyme and lipid profile results and decreased lipid peroxidation and enhanced antioxidant enzyme activities and reduced oxidative stress in DM rats according to biochemical and histopathological results.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • NFE2L2 (Nuclear Factor, Erythroid 2 Like 2) • HMOX1 (Heme Oxygenase 1) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • CASP3 (Caspase 3) • TLR4 (Toll Like Receptor 4) • CAT (Catalase)
10d
Ethyl gallate attenuates 5-flurouracil induced hepatic injury via MAPK/NF-κB downregulation in rats. (PubMed, Toxicol Appl Pharmacol)
Our study demonstrates that EG and SIL treatments effectively alleviate 5-FU-induced acute liver injury by modulating 5-FU catabolism and suppressing the mitogen-activated protein kinase and NF-κB signaling pathways in rats.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • MAPK8 (Mitogen-activated protein kinase 8)
|
5-fluorouracil
11d
Intestinal Protective Effects of a Pomegranate Peel Extract in In Vitro and Ex Vivo Studies. (PubMed, Int J Mol Sci)
PPE mitigates inflammation and oxidative stress, restoring intestinal barrier function. The beneficial effects induced by the extract could be related to the pattern of polyphenolic composition, with particular regard to HT, rosmarinic acid, p-coumaric acid, catechin, as well as punicalagins A and B.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • IL1B (Interleukin 1, beta) • TJP1 (Tight Junction Protein 1) • CAT (Catalase)
17d
Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation, oxidative/nitrative stress, apoptosis and fibrosis. (PubMed, Front Physiol)
This study aims to contrast the protective effects of "Canagliflozin; Cana" versus "Sitagliptin; Sita" in countering the chronic Cd-induced cardiac and hepatic damage. Both medications showed comparable cardio-hepatic protective effects. Yet, Cana outperformed Sita as a potentially effective therapy to counteract the negative consequences of chronic Cd-induced cardiac and hepatic pathologies.
Journal
|
NOTCH1 (Notch 1) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • CASP3 (Caspase 3) • SMAD7 (SMAD Family Member 7) • SMAD3 (SMAD Family Member 3)
19d
Two pediatric supratentorial ependymal tumors with novel PLAG1 fusions. (PubMed, Acta Neuropathol Commun)
They also represent the first PLAG1 fusions identified in pediatric supratentorial ependymal tumors. These cases highlight the value of integrating histology, methylation profiling, and fusion detection, and suggest a new candidate supratentorial ependymal subtype with PLAG1 fusions, pending validation in larger series.
Journal
|
ATRX (ATRX Chromatin Remodeler) • CD34 (CD34 molecule) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • L1CAM (L1 cell adhesion molecule) • PLAG1 (PLAG1 Zinc Finger) • TXNIP (Thioredoxin Interacting Protein) • GFAP (Glial Fibrillary Acidic Protein) • OLIG2 (Oligodendrocyte Transcription Factor 2) • PLAGL2 (PLAG1 Like Zinc Finger 2)
24d
Synthesis of new benzothiazole derivatives with in-depth In-vitro, In-vivo anti-oxidant, anti-inflammatory and anti-ulcer activities. (PubMed, PLoS One)
Additionally, gastric lesions were detected in the ulcer and low Ulcer index confirmed anti-ulcer ability. These results suggest new benzothiazoles which can be further analyzed through clinical studies.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • CAT (Catalase)
27d
Harnessing Dual Power: Genistein-Loaded Pumpkisomes in Pullulan Microneedles for Potent Antioxidant and Anticancer Therapy Against Ehrlich Ascites Carcinoma and Breast Cancer Cells. (PubMed, Pharmaceutics)
Histological study revealed decreased mitotic activity and large tumor cells, with minimal systemic damage. GNS-PKs-pullulan microneedle system offers a hope for an innovative, potent, effective, and non-invasive strategy for breast cancer treatment with high antitumor efficacy.
Journal
|
EGFR (Epidermal growth factor receptor) • IL6 (Interleukin 6) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1)
|
EGFR expression
27d
Targeting Lung Cancer Cell Motility Using Microbeam Radiation Therapy. (PubMed, Cells)
Finally, our data supports potential issues regarding MRT irradiation of key components of the tumor microenvironment, such as fibroblasts. Co-culturing A549 cells with MRT-irradiated MRC-5 lung fibroblasts led to increased tumor cell invasion, not observed when the fibroblasts received BB irradiation.
Journal
|
NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1)
1m
NF-κB Driven Lymphangiogenesis Impacts Kidney Function via a VEGFR-3 Mediated Pathway. (PubMed, JCI Insight)
Compensatory upregulation of PROX-1 and podoplanin occurred despite decreased VEGFR-3 and LYVE-1 total protein expression, suggesting complex regulatory mechanisms. Our findings suggest that RelA is a critical sensor for inflammation and regulator of protective lymphangiogenesis following kidney injury and provide insights into potential therapeutic targets for improved kidney injury outcomes.
Journal
|
FLT4 (Fms-related tyrosine kinase 4) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • LYVE1 (Lymphatic vessel endothelial hyaluronan receptor 1)